Search
for
Sort by
Research 391–420 of 642
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Female doping: observations from a data lake study in the Hospital District of Helsinki and Uusimaa, Finland
- Systemic Lupus Erythematosus
- Injectable Dual‐Crosslinked Poly(oligo(Ethylene Glycol) Methacrylate) Hydrogels Inspired by Mussel Adhesion for Cutaneous Wound Healing and Functional Tissue Regeneration
- POS1510-HPR NUTRITIONAL STATUS AND DIETARY INTAKE ASSESSMENT IN PREGNANT WOMEN WITH RHEUMATIC DISEASES
- Current Management and Treatment Options for Breast Pain
- The immune response to COVID‐19: Does sex matter?
- Short‐Term, Low‐Dose Spironolactone for Treatment of Hyperandrogenic Symptoms of Polycystic Ovary Syndrome—A Systematic Review
- The Effect of Ferritin, Vitamin D, and Some Hormonal and Biochemical Parameters on Patients with Female-pattern Hair Loss after COVID-19 Infection
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- The Transgender: Endocrinological Assessment
- Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- Evidence based medicine: a movement in crisis?
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- Effect of Red Clover Isoflavones over Skin, Appendages, and Mucosal Status in Postmenopausal Women
- The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Evaluating dermatologists’ knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Fractionated CO2 Laser in Combination with Topical Tacrolimus for Chronic Alopecia Areata: A Case Series Study
- Endocrine Management of Adult Gender-Dysphoric/Gender-Incongruent Persons: A Clinical Practice Guideline from Endocrine Society of India
- Effects Of Hormone Therapy On The Laboratory Profile Of Transgender People: A Scoping Review
- Inflammasome Proteins as Biomarkers of Injury and Disease
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome
- Presentation and Management of Cutaneous Manifestations of COVID-19
- Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology